mva cs
Vaccineexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00121771)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva cs
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01739036 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2013 | University of Oxford |
| NCT01623557 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2012 | University of Oxford |
| NCT01450280 | Phase 1 | Dec 1, 2011 | Royal College of Surgeons, Ireland, University of Oxford |
| NCT00377494 | Phase 1 | Sep 14, 2006 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00121771 | Phase 1 | Jan 1, 2004 | Medical Research Council, University of London, University of Oxford |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Oxford | Academic/Hospital | 4 | 3 | 2 | 2004 |
| Medical Research Council | Government | 1 | 0 | 1 | 2004 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2006 |
| Royal College of Surgeons, Ireland | Academic/Hospital | 1 | 0 | 1 | 2011 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2004 |
5 organizations
Page 1 / 1